Friday, December 01, 2017 10:14:49 AM
BlackRock (NYSE:BLK) announces that the Board of Trustees of iShares Trust has authorized a share split for iShares Nasdaq Biotechnology ETF (IBB).
The Board has approved a 3-for-1 split for the fund for shareholders of record as of the close of business on November 28, 2017, payable after the close of trading on November 30, 2017. The 3-for-1 split will lower the share price and increase the number of outstanding shares. The total value of shares outstanding is not affected by the split.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM